Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
What Matters to Patients: Metabolic Health Beyond Weight Loss
Author(s): Lee Kaplan , Fatima Cody Stanford , Filip Knop , et al Added: 2 years ago
Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management. Under the chairmanship of Prof Jason Halford(University of Leeds, UK), the panel includingDr Lee Kaplan(Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US),Dr… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
MANIFEST-REDO
Author(s): Daniel Scherr Added: 1 year ago
AF Symposium 25 - The MANIFEST-REDO sub-study suggests repeat ablation procedures due to clinical recurrence of atrial fibrillation (AF) can be performed safely and with an acceptable success rate.Prof Daniel Scherr (Medical University, Graz, AT) joins us onsite at AF Symposium 25 to discuss the insights from MANIFEST-REDO, investigating repeated ablation following pulmonary vein isolation (PVI)… View more

Electrophysiology & Arrhythmia
Treatment Landscape for Cardiac Amyloidosis with Dr Sarah Cuddy
Author(s): Added: 4 months ago
Discover the rapidly evolving therapeutic options transforming outcomes for cardiac amyloidosis patients with Dr Sarah Cuddy.This comprehensive presentation, part of the Cardiomyopathies track, explores the dramatic advances in both TTR and AL amyloidosis treatment over the past decade. Dr Cuddy examines how modern therapeutic approaches have fundamentally shifted survival curves, particularly… View more

Heart Failure
Bill D Gogas
Job title: Editor-in-Chief, US Cardiology Review
Dr Gogas has more than 10 years of clinical and research experience in cardiology/interventional cardiology. He is current faculty at Nanjing University in China and formerly held a position in the Division of Cardiology of Emory University School of Medicine at the rank of Instructor of Medicine. He received his PhD from Erasmus University, Rotterdam, in 2014 under the mentorship of Prof Patrick… View more
Zero-Contrast PCI Using HD IVUS and Physiological Guidance
Author(s): Joost Daemen , Allen Jeremias , Ziad A Ali Added: 2 years ago
Join us for an informative video that explores the innovative approach of performing zero-contrast percutaneous coronary intervention (PCI) using advanced medical technologies and best practices. In recent years, contrast supply shortages and the need for improved patient outcomes have presented significant challenges in care delivery. In this video, our esteemed faculty will demonstrate the… View more

Imaging & Diagnostics

Intervention
EHRA 24: Insights from an ARTESiA Substudy
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more

Electrophysiology & Arrhythmia
Ethical Challenges in Scientific Publishing: Insights from ESC 2025
Author(s): Alessandro Mugelli Added: 2 months ago

Guidelines & Statements
Nothing to REFINE Yet
Author(s): Gheorghe-Andrei Dan Added: 2 months ago

Guidelines & Statements

Heart Failure